Cytodyn Inc (CYDY)

[C-20]

If Leronlimab wasn’t effective it would have been shutdown a long time ago. The fact that our FDA has no intention of approving us so they would have pounced on the opportunity to dismiss us had we not shown efficacy. The notion that it doesn’t work couldn’t be farther from the truth. CyDy unlike many other drug companies decided to take on a specific area of covid but can be used throughout the process. Take Remdesivir for example the WHO performed a 5000 patient trial and concluded that it showed little to no effect on Covid-19 patients that were hospitalized. Little to no effect but still received the SOC . While we show 24% efficacy in our CD-12 and yes that percentage is correct it was in the results. That’s treating many people who at the time had a very small chance to live . No doubt we should already be approved and LL can start saving lives.